References
- Berman, J. D., Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis., 24, 684-703 (1997) https://doi.org/10.1093/clind/24.4.684
- Bodey, G. P., Anaissie, E. J., Elting, L. S., Estey, E., O'Brien, S., and Kantarjian, H., Antifungal prophylaxis during remission induction therapy for acute leukemia: fluconazole versus intravenous amphotericin B. Cancer, 73, 2099-2106 (1994) https://doi.org/10.1002/1097-0142(19940415)73:8<2099::AID-CNCR2820730814>3.0.CO;2-N
- Borowski, E., Novel approaches in the rational design of antifungal agents of low toxicity. Farmaco, 55, 206-208 (2000) https://doi.org/10.1016/S0014-827X(00)00024-0
- Brajtburg, J., Powderly, W. G., Kobayashi, G. S., and Madoff, G., Amphotericin B: delivery systems. Antimicrob. Agents Chemother., 34, 381-384 (1990) https://doi.org/10.1128/AAC.34.3.381
- Branch, R. A., Prevention of amphotericin B-induced renal impairment: a review on the use of sodium supplementation. Arch. Intern. Med., 148, 2389-2394 (1988) https://doi.org/10.1001/archinte.148.11.2389
- Brime, B., Molero, G.., Frutos P., and Frutos, G.., Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and deoxycholateamphotericin B in immunocompetent and neutropenic mice infected with Candida albicans. Eur. J. Pharm. Sci., 22, 451- 458 (2004) https://doi.org/10.1016/j.ejps.2004.04.008
- Carpino, L. A. and Han, G.. Y., 9-Fluorenylmethoxycarbonyl amino-protecting group. J. Org. Chem., 37, 3404-3409 (1972) https://doi.org/10.1021/jo00795a005
- Chernushevich, I. V., Loboda, A. V., and Thomson, B. A., An introduction to quadrupole.time-of-flight mass spectrometry. J. Mass Spectrom., 36, 849.865 (2001) https://doi.org/10.1002/jms.207
- Kaloyanides G. J., Antibiotic-related nephrotoxicity. Nephrol. Dial. Transplant., 9 (suppl 4), 130-134 (1994)
- Kishore, B. K., Kallay Z, Lambricht P, Laurent G, and Tulkens P. M., Mechanism of protection afforded by polyaspartic acid against gentamycin-induced phospholipidosis I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro. J. Pharmacol. Exp. Ther., 255, 867-874 (1990a)
- Kishore, B. K., Lambricht, P., Laurent, G., Maldague, P., Wagner, R., and Tulkens, P. M., Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic, and poly-D-glutamic acids. J. Pharmacol. Exp. Ther., 255, 875-885 (1990b)
- Mann, M., Hendrickson, R. C., and Pandey, A., Analysis of proteins and proteomes by mass spectrometry. Annu. Rev. Biochem., 70, 437-473 (2001) https://doi.org/10.1146/annurev.biochem.70.1.437
- Merrifield, R. B., Solid phase peptide synthesis: the synthesis of a tetrapeptide. J. Am. Chem. Soc., 85, 2149-2154 (1963) https://doi.org/10.1021/ja00897a025
- Meyer, R. D., Young, L. S., Armstrong, D., and Yu, B., Aspergillosis complicating neoplastic disease. Am. J. Med., 54, 6-15 (1973) https://doi.org/10.1016/0002-9343(73)90077-6
- Miranda, L. P. and Alewood, P. F., Accelerated chemical synthesis of peptides and small proteins. Proc. Natl. Acad. Sci. U.S.A., 96, 1181-1186 (1999) https://doi.org/10.1073/pnas.96.4.1181
- Mullen, A. B., Carter, K. C., and Baillie, A. J., Comparison of the efficacies of various formations of amphotericin B against murine visceral leishmaniasis. Antimicrob. Agents Chemother., 41, 2089-2092 (1997)
- Saxena, S. and Ghosh, P. C., Biodistribution of amphotericin B when delivered through cholesterol hemisuccinate vesicles in normal and A. fumigatus infected mice. Pharm. Res., 17, 1236-1242 (2000) https://doi.org/10.1023/A:1026418814417
- Sheppard, R. C., Modern methods of solid-phase peptide synthesis. Science Tools, 33, 122-129 (1986)
- Townsend, R. W., Zutshi, A., and Bekersky, I., Biodistribution of 4-[(14) C] cholesterol-Ambisome following a single intravenous administration to rats. Drug Metb. Dispos., 29. 681- 685 (2001)
- Warnock, D. W., Amphotericin B: an introduction. J. Antimicrob. Chemother., 28(Suppl. B), 27-38 (1991) https://doi.org/10.1093/jac/28.suppl_B.27
- Wiebe, V. J. and DeGregorio, M. W., Liposome-encapsulated amphotericin B: a promising new treatment for disseminated fungal infections. Rev. Infect. Dis., 10, 1097-1101 (1988) https://doi.org/10.1093/clinids/10.6.1097
- Whitelegge, J. P., Gundersen, C. B., and Faull, K. E., Electrosprayionization mass spectrometry of intact intrinsic membrane proteins. Protein Science, 7, 1423-1430 (1998) https://doi.org/10.1002/pro.5560070619